Reproductive Endocrinology Practice Questions

Q: Cervical mucus has which of the following properties EXCEPT?

High estrogen levels at midcycle make cervical mucus thick. **Explanation:** The correct answer is **A**. This statement is incorrect because high estrogen levels at midcycle (periovulatory phase) make the cervical mucus **thin, watery, and profuse**, not thick. Under the influence of estrogen, the mucus becomes less viscous to facilitate the rapid transport of sperm into the upper reproductive tract. **Analysis of Options:** * **Option A (Correct):** Estrogen increases the water content of cervical mucus (up to 98%), making it thin and stretchy (Spinnbarkeit effect). Thick, tenacious mucus is a characteristic of the **progesterone-dominant** luteal phase or pregnancy, which acts as a barrier to sperm. * **Option B:** Estrogen-primed mucus acts as a biological filter, allowing motile sperm to pass while trapping seminal plasma, cellular debris, and morphologically abnormal sperm. * **Option C:** The cervical crypts serve as a reservoir, protecting sperm from the acidic vaginal environment and releasing them into the uterus over several days. * **Option D:** Estrogen increases the concentration of sodium chloride and potassium. When this mucus dries on a slide, the salt crystals form a characteristic "palm-leaf" or **ferning pattern**, a classic indicator of high estrogen levels. **High-Yield NEET-PG Pearls:** * **Spinnbarkeit Effect:** The ability of midcycle mucus to be stretched into a long thread (usually >8-10 cm). * **Ferning Pattern:** Maximum at ovulation (Day 14); disappears after Day 21 due to progesterone. * **Progesterone Effect:** Makes mucus thick, cellular, and creates a "hostile" environment for sperm. * **Insler Score:** A clinical scoring system used to assess cervical mucus quality (volume, spinnbarkeit, ferning, and cervical os opening).

Q: What is the most common endocrine disorder affecting women of reproductive age?

Polycystic ovarian syndrome. **Explanation:** **Polycystic Ovarian Syndrome (PCOS)** is the correct answer as it is the most common endocrine-metabolic disorder affecting women of reproductive age globally. Its prevalence ranges from **5% to 15%** depending on the diagnostic criteria used (Rotterdam, NIH, or AE-PCOS Society). It is characterized by a combination of hyperandrogenism (clinical or biochemical), ovulatory dysfunction, and polycystic ovarian morphology on ultrasound. **Analysis of Incorrect Options:** * **Hypothyroidism:** While common, its prevalence in reproductive-age women is approximately 2–4%. It is a frequent cause of secondary amenorrhea but is less prevalent than PCOS. * **Type-2 Diabetes Mellitus:** Although rising due to obesity, it typically manifests later in life. While PCOS increases the risk of developing Type-2 DM, the primary endocrine diagnosis remains PCOS in this demographic. * **Congenital Adrenal Hyperplasia (CAH):** Specifically the Non-Classic form (NCCAH), it can mimic PCOS symptoms (hirsutism, oligomenorrhea). However, it is a rare genetic disorder with a much lower prevalence (approx. 0.1–1%). **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** The **Rotterdam Criteria** (requires 2 out of 3: Oligo/Anovulation, Hyperandrogenism, PCO on Ultrasound). * **LH:FSH Ratio:** Classically **3:1** (though no longer a formal diagnostic criterion). * **Pathophysiology:** Hyperinsulinemia and insulin resistance are central, leading to increased theca cell androgen production. * **DOC for Ovulation Induction:** **Letrozole** (Aromatase inhibitor) is now preferred over Clomiphene Citrate. * **Long-term Risks:** Endometrial carcinoma (due to unopposed estrogen), Metabolic Syndrome, and Type-2 DM.

Q: In which of the following conditions do the ovaries function normally?

Rokitansky-Kuster-Hauser syndrome. **Explanation:** The core concept tested here is the embryological origin of the female reproductive system. The ovaries develop from the **primitive germ cells** (genital ridge), whereas the uterus, cervix, and upper vagina develop from the **Müllerian (paramesonephric) ducts**. **1. Why Rokitansky-Kuster-Hauser (MRKH) Syndrome is correct:** MRKH syndrome is characterized by **Müllerian Agenesis**. Because the ovaries have a different embryological origin than the Müllerian ducts, they develop and function normally. Patients have a female karyotype (46, XX), normal secondary sexual characteristics (due to estrogen from functional ovaries), and normal ovulation, but present with primary amenorrhea due to the absence of the uterus and upper vagina. **2. Why the other options are incorrect:** * **Turner’s Syndrome (45, XO):** Accelerated atresia of germ cells leads to **"streak ovaries"** and primary ovarian failure. Estrogen levels are low, and FSH is elevated. * **Androgen Insensitivity Syndrome (46, XY):** These individuals have **testes**, not ovaries. The testes produce testosterone (converted to estrogen peripherally) and Anti-Müllerian Hormone (AMH), which causes the absence of a uterus. * **Swyer’s Syndrome (46, XY Pure Gonadal Dysgenesis):** Due to a failure in testicular development, the gonads remain as non-functional **streaks**. There are no functioning ovaries. **High-Yield Clinical Pearls for NEET-PG:** * **MRKH Syndrome:** Most common cause of primary amenorrhea with normal secondary sexual characteristics. * **Association:** Always screen for **renal anomalies** (e.g., renal agenesis, pelvic kidney) in MRKH patients (found in ~30-40%). * **Hormonal Profile in MRKH:** Normal FSH, LH, and Estrogen (confirms normal ovarian axis). * **Management:** Neovagina creation (Frank’s dilators or McIndoe procedure); pregnancy is possible only via surrogacy.

Q: In hypergonadotropic hypogonadism, what is the typical FSH level?

Greater than 40 mIU/mL. ### Explanation **Concept Overview:** Hypergonadotropic hypogonadism refers to **primary gonadal failure**. In this condition, the defect lies within the ovaries (e.g., Premature Ovarian Failure or Menopause). Because the ovaries fail to produce estrogen and inhibin, there is a loss of negative feedback on the pituitary gland. This results in a compensatory, massive increase in the secretion of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH). **Why Option D is Correct:** In clinical practice and for NEET-PG purposes, an **FSH level >40 mIU/mL** is the diagnostic hallmark of permanent ovarian failure or menopause. While levels above 20 mIU/mL indicate declining ovarian reserve, the threshold of 40 mIU/mL is specifically used to define the "hypergonadotropic" state associated with complete gonadal failure. **Analysis of Incorrect Options:** * **Options A & B ( 20 mIU/mL):** While FSH levels between 20–40 mIU/mL are elevated and suggest "incipient" ovarian failure or decreased ovarian reserve, they do not meet the definitive diagnostic criteria for hypergonadotropic hypogonadism (menopausal range). **NEET-PG High-Yield Pearls:** * **Gold Standard Marker:** FSH is the most sensitive marker for diagnosing menopause/primary ovarian failure. * **Premature Ovarian Failure (POF):** Defined as secondary amenorrhea with FSH >40 mIU/mL on two occasions (at least 1 month apart) in a woman aged 2:1, but in hypergonadotropic hypogonadism, both are elevated, with FSH typically rising higher and earlier than LH. * **Kallmann Syndrome:** A classic example of *Hypogonadotropic* hypogonadism (Low FSH/LH + Anosmia).

Q: Precocious puberty is most characteristic of which of the following conditions?

Albright's syndrome. **Explanation:** **Albright’s Syndrome** (specifically McCune-Albright Syndrome) is the correct answer because it is a classic cause of **GnRH-independent (peripheral) precocious puberty**. It is characterized by a clinical triad: 1. **Polyostotic fibrous dysplasia:** Multiple cystic bone lesions. 2. **Café-au-lait spots:** Large, irregular skin pigmentations (often described as having "Coast of Maine" borders). 3. **Autonomous endocrine hyperfunction:** Most commonly presenting as precocious puberty due to estrogen secretion from ovarian cysts. The underlying pathophysiology involves a somatic mutation in the **GNAS gene**, leading to constitutive activation of the G-protein signaling (adenylate cyclase), which mimics the effect of continuous hormonal stimulation (FSH/LH) on the ovaries. **Analysis of Incorrect Options:** * **Jaffe’s Syndrome:** This is a variant of fibrous dysplasia that presents with café-au-lait spots and bone lesions but **lacks** the endocrine abnormalities (precocious puberty) seen in McCune-Albright. * **Monostotic fibrous dysplasia:** This involves a single bone lesion and is not associated with systemic endocrine manifestations or skin pigmentation. * **Osteogenesis imperfecta:** A genetic disorder of Type 1 collagen characterized by brittle bones, blue sclera, and hearing loss, but it does not cause precocious puberty. **High-Yield Clinical Pearls for NEET-PG:** * **McCune-Albright Syndrome** is more common in girls. * It is a **peripheral** cause of precocious puberty; therefore, LH/FSH levels will be suppressed (low), and the patient will not respond to GnRH analogues. * The café-au-lait spots in this syndrome are typically unilateral and do not cross the midline. * **Treatment:** Aromatase inhibitors (e.g., Letrozole) or Estrogen receptor antagonists (e.g., Tamoxifen) are used to manage the precocity.

Q: A sample of cervical mucus is taken on Day 12 of the menstrual cycle. The mucus is thin, clear, and elastic. When placed under a microscope, what microscopic finding would be expected?

A fern pattern characteristic of estrogen. **Explanation:** The correct answer is **C. A fern pattern characteristic of estrogen.** **1. Why the correct answer is right:** On Day 12 of a typical 28-day menstrual cycle (the late follicular/pre-ovulatory phase), estrogen levels are at their peak. High estrogen levels act on the cervical glands to produce mucus that is thin, watery, alkaline, and rich in sodium chloride. When this mucus is dried on a glass slide, the crystallization of the salts creates a characteristic microscopic appearance known as **arborization** or a **"fern pattern."** This change increases the "Spinnbarkeit" (elasticity), facilitating sperm penetration and survival. **2. Why the incorrect options are wrong:** * **Option A:** While the mucus is clear clinically, a "clear field" under a microscope is not a diagnostic finding for cycle dating. The presence or absence of bacteria is not the defining feature of the periovulatory phase. * **Option B:** Thick mucus with background cellularity/bacteria is characteristic of the **luteal phase** (post-ovulation). Under the influence of **progesterone**, cervical mucus becomes thick, viscous, and cellular, which inhibits the fern pattern (anti-estrogenic effect). * **Option D:** Parabasal cells are a feature of vaginal cytology in low-estrogen states (e.g., menopause or prepuberty), not a finding in cervical mucus during the reproductive cycle. **3. NEET-PG High-Yield Pearls:** * **Ferning (Arborization):** Indicates high estrogen; disappears after Day 21 due to progesterone. * **Spinnbarkeit Test:** Measures the elasticity of mucus. Maximum elasticity (>10 cm) occurs just before ovulation. * **Progesterone Effect:** Causes "Beading" or a cellular pattern; it is the basis for using cervical mucus as a natural contraceptive method (Billings method). * **Palm Leaf Pattern:** Another name for the fern pattern seen in cervical mucus.

Q: Which of the following clinical features is seen in Polycystic Ovarian Disease (PCOD)?

Streak ovaries. **Explanation:** The question asks for a clinical feature **not** typically associated with Polycystic Ovarian Disease (PCOD/PCOS), as **Streak Ovaries** is the characteristic finding in **Turner Syndrome (45,XO)** and Pure Gonadal Dysgenesis, not PCOD. **1. Why "Streak Ovaries" is the Correct Answer (The Exception):** In PCOD, the ovaries are typically **enlarged** (volume >10cc) with multiple small peripheral follicles (string-of-pearls appearance). In contrast, **streak ovaries** occur due to accelerated atresia of germ cells, resulting in fibrous tissue bands devoid of follicles. This is a hallmark of hypergonadotropic hypogonadism (e.g., Turner Syndrome). **2. Analysis of Incorrect Options:** * **Hirsutism:** This is a classic feature of PCOD, resulting from **hyperandrogenism**. It is clinically graded using the Modified Ferriman-Gallwey score. * **Secondary Amenorrhea:** PCOD is the most common cause of chronic anovulation. Patients typically present with oligomenorrhea or secondary amenorrhea due to the lack of progesterone withdrawal. * **Elevated FSH/LH ratio:** This is a distractor. In PCOD, the **LH/FSH ratio is increased** (typically >2:1 or 3:1) because of increased GnRH pulse frequency. Therefore, a "decreased" FSH/LH ratio is seen, but the presence of hormonal imbalance remains a core feature. **High-Yield Clinical Pearls for NEET-PG:** * **Rotterdam Criteria (2 out of 3):** 1. Clinical/Biochemical Hyperandrogenism, 2. Oligo/Anovulation, 3. Polycystic ovaries on USG. * **Gold Standard Investigation:** Transvaginal Ultrasound (TVS). * **Metabolic Link:** Hyperinsulinemia and Insulin Resistance are central to the pathogenesis. * **Drug of Choice:** Clomiphene Citrate (traditional) or **Letrozole** (current first-line for ovulation induction).

Q: Which of the following is NOT a typical sign of hyperandrogenism seen in Polycystic Ovary Syndrome (PCOS)?

Clitoromegaly. **Explanation:** In Polycystic Ovary Syndrome (PCOS), hyperandrogenism is typically **biochemical** (elevated serum testosterone/androstenedione) or **clinical** (signs of mild-to-moderate androgen excess). **Why Clitoromegaly is the correct answer:** Clitoromegaly is a sign of **virilization**, not simple hyperandrogenism. Virilization involves extreme androgen excess that causes masculine physical changes, including clitoromegaly (clitoral index >35 $mm^2$), deepening of the voice, and increased muscle mass. If a patient presents with these signs, clinicians must rule out more serious pathologies like **Androgen-Secreting Ovarian Tumors** (e.g., Sertoli-Leydig cell tumors) or **Adrenal Tumors**, as PCOS rarely produces androgen levels high enough to cause structural changes like clitoromegaly. **Analysis of Incorrect Options:** * **A. Hirsutism:** The most common clinical sign of PCOS (seen in ~70% of cases), characterized by terminal hair growth in a male-pattern distribution (measured by the Modified Ferriman-Gallwey score). * **C. Androgenic Alopecia:** Thinning of scalp hair, typically in the vertex or crown area, is a recognized cutaneous manifestation of hyperandrogenism in PCOS. * **D. Acne:** Persistent inflammatory acne, especially in the "U-zone" (jawline), is a common dermatological marker of elevated circulating androgens. **NEET-PG High-Yield Pearls:** * **Rotterdam Criteria (2003):** Diagnosis requires 2 out of 3: (1) Oligo/Anovulation, (2) Hyperandrogenism (Clinical/Biochemical), (3) Polycystic ovaries on USG. * **Virilization vs. Hyperandrogenism:** PCOS = Hyperandrogenism; Ovarian/Adrenal Tumors = Virilization. * **Gold Standard for Hirsutism:** Modified Ferriman-Gallwey (mFG) score; a score $\geq$ 8 is significant in the Indian population.

Question 1

Cervical mucus has which of the following properties EXCEPT?

Accepted Answer

High estrogen levels at midcycle make cervical mucus thick

Answer

Estrogen-primed cervical mucus filters out non-sperm components of semen

Answer

Midcycle mucus creates a reservoir for sperm

Answer

Elevated estrogen levels near ovulation increase sodium chloride concentration

Question 2

What is the most common endocrine disorder affecting women of reproductive age?

Accepted Answer

Polycystic ovarian syndrome

Answer

Hypothyroidism

Answer

Type-2 Diabetes mellitus

Answer

Congenital adrenal hyperplasia

Question 3

In which of the following conditions do the ovaries function normally?

Accepted Answer

Rokitansky-Kuster-Hauser syndrome

Answer

Turner's syndrome

Answer

Androgen insensitivity syndrome

Answer

Swyer's syndrome

Question 4

In hypergonadotropic hypogonadism, what is the typical FSH level?

Accepted Answer

Greater than 40 mIU/mL

Answer

Less than 20 mIU/mL

Answer

Less than 40 mIU/mL

Answer

Greater than 20 mIU/mL

Question 5

What percentage of pregnancies are affected by Hemorrhagic Motivation Group (HMG)?

Accepted Answer

30%

Answer

5%

Answer

10%

Answer

20%

Question 6

Precocious puberty is most characteristic of which of the following conditions?

Accepted Answer

Albright's syndrome

Answer

Jaffe's Syndrome

Answer

Monostotic fibrous dysplasia

Answer

Osteogenesis imperfecta

Question 7

Which of the following prostaglandins induces aromatase activity in endometrial stromal cells?

Accepted Answer

PGE2

Answer

PGE1

Answer

PGF2

Answer

PGD2

Question 8

A sample of cervical mucus is taken on Day 12 of the menstrual cycle. The mucus is thin, clear, and elastic. When placed under a microscope, what microscopic finding would be expected?

Accepted Answer

A fern pattern characteristic of estrogen

Answer

Clear field devoid of bacteria

Answer

Thick mucus with background bacteria

Answer

Clearly defined, parabasal cells

Question 9

Which of the following clinical features is seen in Polycystic Ovarian Disease (PCOD)?

Accepted Answer

Streak ovaries

Answer

Hirsutism

Answer

Secondary amenorrhea

Answer

Elevated FSH/LH ratio

Question 10

Which of the following is NOT a typical sign of hyperandrogenism seen in Polycystic Ovary Syndrome (PCOS)?

Accepted Answer

Clitoromegaly

Answer

Hirsutism

Answer

Androgenic Alopecia

Answer

Acne

Reproductive Endocrinology — MCQs

Reproductive Endocrinology — MCQs

On this page

Practice by Chapter

Want unlimited practice?